Literature DB >> 16484399

Bleeding complications after endovascular therapy of cerebral arteriovenous malformations.

J O Heidenreich1, S Hartlieb, R Stendel, T A Pietilä, P Schlattmann, K-J Wolf, A M Schilling.   

Abstract

BACKGROUND AND
PURPOSE: Intracerebral hemorrhages after embolization of arteriovenous malformations (AVMs) are the most dreaded complications of this well-established therapy. Apart from the known risk factors, our center noticed a high incidence of complications during postinterventional monitoring in medical intensive care units (ICUs) and stroke units.
MATERIALS AND METHODS: We report 125 consecutive interventions performed on 66 patients by using flow-dependent microcatheters and n-butyl cyanoacrylate as the embolic agent. Postinterventional intensive care monitoring was performed in an interdisciplinary operative ICU, a stroke unit, or a medical ICU. Patients were compared with regard to bleeding complications, AVM morphology, embolization result, postinterventional monitoring, and demographic factors.
RESULTS: Intracerebral hemorrhages occurred in 7 patients. Significant differences in outcome were found between 66 patients monitored in the interdisciplinary operative ICU from medical ICU or stroke unit. This was also true when adjusted for age and extent of AVM reduction by using exact logistic regression. A partial AVM reduction of >60% was a considerable risk factor for hemorrhage (odds ratio [OR] = 18.8; 95% confidence interval [CI] [1.341, not available]. Age was also an essential risk factor. An age difference of 10 years leads to an OR of 2.545 (95% CI [1.56, 7.35]). DISCUSSION: A considerable AVM reduction in one session appears to increase the risk of hemorrhage technically. This suggests a distribution of the interventions in many partial steps.

Entities:  

Mesh:

Year:  2006        PMID: 16484399      PMCID: PMC8148774     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  17 in total

1.  Blood pressure changes in feeders to cerebral arteriovenous malformations during therapeutic embolization.

Authors:  C A Jungreis; J A Horton; S T Hecht
Journal:  AJNR Am J Neuroradiol       Date:  1989 May-Jun       Impact factor: 3.825

2.  Normal perfusion pressure breakthrough theory.

Authors:  R F Spetzler; C B Wilson; P Weinstein; M Mehdorn; J Townsend; D Telles
Journal:  Clin Neurosurg       Date:  1978

Review 3.  Acute spontaneous hemorrhage after embolization of brain arteriovenous malformation with N-butyl cyanoacrylate.

Authors:  L Picard; E Da Costa; R Anxionnat; J Macho; S Bracard; A Per; J C Marchal
Journal:  J Neuroradiol       Date:  2001-09       Impact factor: 3.447

4.  Evaluation of pressure changes in feeding arteries during embolization of intracerebral arteriovenous malformations.

Authors:  T Handa; M Negoro; S Miyachi; K Sugita
Journal:  J Neurosurg       Date:  1993-09       Impact factor: 5.115

5.  Progressive thrombosis of brain arteriovenous malformations after embolization with isobutyl 2-cyanoacrylate.

Authors:  F Viñuela; A J Fox; G Debrun; C G Drake; S J Peerless; J P Girvin
Journal:  AJNR Am J Neuroradiol       Date:  1983 Nov-Dec       Impact factor: 3.825

6.  Blood pressure monitoring in feeding arteries of cerebral arteriovenous malformations during embolization: a preventive role in hemodynamic complications.

Authors:  T Sorimachi; S Takeuchi; T Koike; T Minakawa; H Abe; R Tanaka
Journal:  Neurosurgery       Date:  1995-12       Impact factor: 4.654

7.  The safety and effectiveness of brain arteriovenous malformation embolization using acrylic and particles: the experiences of a single institution.

Authors:  R C Wallace; R A Flom; M H Khayata; B L Dean; J McKenzie; J C Rand; N A Obuchowski; R C Zepp; J M Zabramski; R F Spetzler
Journal:  Neurosurgery       Date:  1995-10       Impact factor: 4.654

8.  The effect of embolization with N-butyl cyanoacrylate prior to surgical resection of cerebral arteriovenous malformations.

Authors:  J J Jafar; A J Davis; A Berenstein; I S Choi; M J Kupersmith
Journal:  J Neurosurg       Date:  1993-01       Impact factor: 5.115

9.  The influence of hemodynamic and anatomic factors on hemorrhage from cerebral arteriovenous malformations.

Authors:  A Kader; W L Young; J Pile-Spellman; H Mast; R R Sciacca; J P Mohr; B M Stein
Journal:  Neurosurgery       Date:  1994-05       Impact factor: 4.654

10.  Occlusion of cerebral arteriovenous malformations with N-butyl cyano-acrylate is permanent.

Authors:  G Wikholm
Journal:  AJNR Am J Neuroradiol       Date:  1995-03       Impact factor: 3.825

View more
  18 in total

1.  Superior vena cava syndrome caused by embolisation of liquid Onyx.

Authors:  Robbert Crusio; Kishan Ramachandran; Kavan Ramachandran; Yizhak Kupfer; Sidney Tessler
Journal:  BMJ Case Rep       Date:  2011-02-14

2.  Current status and future prospect of endovascular neurosurgery.

Authors:  Young Il Jeon; Do Hoon Kwon
Journal:  J Korean Neurosurg Soc       Date:  2008-02-20

3.  Assessment of periprocedural hemodynamic changes in arteriovenous malformation vessels by endovascular dual-sensor guidewire.

Authors:  Kirill Orlov; Vyacheslav Panarin; Alexey Krivoshapkin; Dmitry Kislitsin; Vadim Berestov; Timur Shayakhmetov; Anton Gorbatykh
Journal:  Interv Neuroradiol       Date:  2015-02       Impact factor: 1.610

Review 4.  Clinical Presentation, Imaging, and Management of Complications due to Neurointerventional Procedures.

Authors:  Matthew C Davis; John P Deveikis; Mark R Harrigan
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

5.  Evaluation of 4D vascular flow and tissue perfusion in cerebral arteriovenous malformations: influence of Spetzler-Martin grade, clinical presentation, and AVM risk factors.

Authors:  C Wu; S A Ansari; A R Honarmand; P Vakil; M C Hurley; B R Bendok; J Carr; T J Carroll; M Markl
Journal:  AJNR Am J Neuroradiol       Date:  2015-02-26       Impact factor: 3.825

6.  Clinical features and endovascular treatment of intracranial arteriovenous malformations in pediatric patients.

Authors:  Tao Zheng; Qiu-Jing Wang; Ya-Qi Liu; Xu-Bo Cui; Yu-Yuan Gao; Ling-Feng Lai; Shi-Xing Su; Xin Zhang; Xi-Feng Li; Xu-Ying He; Chuan-Zhi Duan
Journal:  Childs Nerv Syst       Date:  2013-09-08       Impact factor: 1.475

7.  Brain AVM embolization with Onyx.

Authors:  W J van Rooij; M Sluzewski; G N Beute
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

8.  Periprocedural bleeding complications of brain AVM embolization with Onyx.

Authors:  L Liu; C Jiang; H He; Y Li; Z Wu
Journal:  Interv Neuroradiol       Date:  2010-03-25       Impact factor: 1.610

9.  Predictors of hemorrhagic complications from endovascular treatment of cerebral arteriovenous malformations.

Authors:  José A Jordan; Juan Carlos Llibre; Frank Vázquez; Raúl Rodríguez; José A Prince; José Carlos Ugarte
Journal:  Interv Neuroradiol       Date:  2014-02-10       Impact factor: 1.610

10.  Predictors of neurological deficit after endovascular treatment of cerebral arteriovenous malformations and functional repercussions in prospective follow-up.

Authors:  Jose Jordan; Juan Carlos Llibre; Frank Vazquez
Journal:  Neuroradiol J       Date:  2014-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.